CI Platform
Sign in
Handa Pharmaceuticals Inc6620Unknown exchange
Current ReportFundamental Reports

Asia / TAIWAN

Report Sections1

Available for this company

Reporting UnitBillions

Unknown exchange

Company Overview

Handa Pharmaceuticals, Inc. engages in the research, development, design, and sale of pharmaceutical business. It focuses on the development of niche drug. It offers 505(b)2 new drugs, high-tech generic drugs and other biotechnology services. The company was founded by Yu Ling Fang on May 8, 2014 and is headquartered in Tainan, Taiwan.

Handa Pharmaceuticals, Inc. engages in the research, development, design, and sale of pharmaceutical business. It focuses on the development of niche drug. It offers 505(b)2 new drugs, high-tech generic drugs and other biotechnology services. The company was founded by Yu Ling Fang on May 8, 2014 and is headquartered in Tainan, Taiwan.

Includes quarterly earnings and dividends.

Company Details

Major IndustryPharmaceuticals & Biotechnology
Sub IndustryPharmaceutical Preparations
CountryTAIWAN
Employees50
Reporting UnitBillions
Primary ExchangeUnknown exchange
Instrument TypeEquity
Websitehttp://handapharma.com.tw/en
Wright IDC158WXDVX

Key Metrics

Current price$126.50
Market cap$20.05 B
P/E ratio41.37
52-week perf.+1.9%
Common shares158.5 M
Share typeGu
Quality ratingCAD0
Dividend yield0.79%

Recent stock performance

1 Week-4.5%
4 Week-11.8%
13 Week+43.9%

Officers

ChairmanFangyu Liu
Chief Technology OfficerGuojun Song

Address

Nanbu Kexue Gongye Yuan District

XINSHI

TAIWAN

741

Phonen/a

Quarterly Earnings & Dividends

Quarterly earnings and dividend history is not available for this company.

Try another report for annual statements, Wright Quality history or comparative analysis.